Many have long sensed that women spend more on prescription medications than men as women have to manage more medical ...

GoodRx’s brand new CEO, Wendy Barnes, says her job is not so much to fix anything, but to speed up the company’s current ...

GoodRx is down 4.5% during the same time and is heading into earnings with an average analyst price target of $6.88 (compared to the current share price of $4.67). Unless you’ve been living ...

Observing a downward trend, the current average is 12.53% lower than the prior average price target of $7.50. Understanding Analyst Ratings: A Comprehensive Breakdown A clear picture of GoodRx ...

GoodRx periodically posts information that may ... changes in medication pricing and pricing structures; our reliance on a limited number of industry participants; and the important factors ...

Overview: GoodRx Holdings, Inc. provides tools and information for consumers to compare prices and save on prescription drug purchases in the United States, with a market cap of approximately $1. ...